Key result
Prostacyclin analogs reduced pulmonary arterial smooth muscle cell proliferation by approximately 40% in idiopathic pulmonary arterial hypertension via a PPARγ-dependent pathway, despite IP receptor down-regulation.
Prostacyclin analogs inhibit smooth muscle proliferation in IPAH through a PPARγ-dependent pathway despite IP receptor down-regulation.
Answers are grounded in this paper and cite their sources.
Extends mechanistic insight into prostacyclin effects in IPAH models via PPARγ; leaves open clinical translation pending human studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Falcetti et al. (2010) studied Idiopathic Pulmonary Arterial Hypertension (n=29). Prostacyclin analogs (treprostinil, iloprost) vs. Vehicle control (FBS alone) was evaluated on Cell proliferation (40% reduction, p=<0.001). Prostacyclin analogs reduced pulmonary arterial smooth muscle cell proliferation by approximately 40% in idiopathic pulmonary arterial hypertension via a PPARγ-dependent pathway, despite IP receptor down-regulation.
Synapse has enriched 10 related papers. Consider them for comparative context: